2017-08-30

Daiichi Sankyo Enters Worldwide Licensing Agreement with Boston Pharmaceuticals for a Highly Selective RET Inhibitor for Solid Tumors

2017-07-25

Gurnet Point L.P. Completes Acquisition of Innocoll Holdings plc

2017-04-05

Gurnet Point L.P. enters into agreement to acquire Innocoll Holdings plc

2016-12-07

Gurnet Point Invests $92M in Primary Care Innovator Crossover Health

2016-11-15

Gurnet Point Capital Invests in BEFORE Brands

2015-11-19

Gurnet Point Capital launches new drug development company, Boston Pharmaceuticals

2015-06-23

Gurnet Point appoints Chris Viehbacher to lead healthcare investment strategy